Chemotherapy News and Research

Latest Chemotherapy News and Research

Chinese herbs may help women with breast cancer

Using Chinese herbs either alone or in conjunction with chemotherapy may help protect a breast cancer patient’s bone marrow and immune system, as well as improving the woman’s overall quality of life.

19 Apr 2007

Preoperative chemotherapy is safe for women with early stage operable breast cancer

Chemotherapy is frequently given to women with breast cancer after surgery to remove the main bulk of the tumour.

19 Apr 2007

Novel method to expand the number of immune system "natural killer" cells from blood cells outside the body

Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have devised a novel method to expand the number of immune system "natural killer (NK)" cells from blood cells outside the body.

19 Apr 2007

Genta Incorporated announces phase 3 trial of Genasense in patients with advanced melanoma

Genta Incorporated has announced that the Company will conduct a new randomized controlled Phase 3 trial of its lead anticancer product, Genasense (oblimersen sodium) Injection, in patients with advanced melanoma.

19 Apr 2007

Vaccines to prevent or slow the growth of cancerous tumors

Mayo Clinic researchers have designed a new strategy in the promising field of cancer vaccine research that's proven to be successful in boosting T cells - the immune builders akin to a super defense force against cancer cells.

19 Apr 2007

No survival benefit for gastric cancer patients who undergo intensive postoperative chemotherapy

A more intensive postoperative chemotherapy regimen for high-risk gastric cancer patients did not improve their survival, according to a randomized controlled trial in the April 18 Journal of the National Cancer Institute .

18 Apr 2007

Factors that dictate risk of developing primary or secondary cancer

Every day, people make assumptions, educated and not, about their risk for developing cancer.

18 Apr 2007

Vaccine halts progression of pancreatic cancer in some patients

A dendritic cell-based therapeutic vaccine for pancreatic cancer developed by researchers at the University of Pittsburgh School of Medicine has successfully stalled the disease from progressing in a handful of patients three years post-vaccination.

18 Apr 2007

OncoGenex Technologies announces data from a Phase II clinical trial of OGX-011

The primary objective of this study was to assess the objective response rates (reduction in tumor size) when OGX-011 is combined with docetaxel in patients with metastatic or locally recurrent breast cancer.

18 Apr 2007

North Shore-LIJ seeks participants for liver tumor and new chemo trial

The North Shore-LIJ Health System has announced it is seeking participants for a new clinical trial that will test a new chemotherapy option for patients with liver tumors.

18 Apr 2007

Nanoparticle delivery system delivers cancer-suppressing gene in M. D. Anderson trial

A cancer-suppressing gene has been successfully delivered into the tumors of stage 4 lung cancer patients via an intravenously administered lipid nanoparticle in a phase I clinical trial at The University of Texas M. D. Anderson Cancer Center.

18 Apr 2007

Scientists tackle cancer with different approaches

Studies presented at the 2007 meeting of the American Association for Cancer Research show how researchers are using the new, as well as the natural, to help design and test new drugs to treat cancer.

18 Apr 2007

Polymorphisms in the glutathione S-transferase genes and treatment outcomes in acute myeloid leukemia

Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April 14-18, in Los Angeles, CA.

18 Apr 2007

Cell Genesys reports data from clinical trials of GVAX immunotherapy for prostate cancer

Evaluation of antibody responses in patients with advanced prostate cancer from these studies shows that the GVAX cell-based immunotherapy induces antibody responses to a broad array of prostate cancer- associated antigens, including some not previously known to be associated with prostate cancer.

18 Apr 2007

Cancer patients are at high risk for potential drug interactions

Potential drug interactions from prescribed medications are common among cancer patients and may cause unnecessary harm, according to a study in the April 18 Journal of the National Cancer Institute .

18 Apr 2007

Advanced age associated with poorer bladder cancer-specific survival in radical cystectomy patients

Traditional wisdom taught in urological residency has been that healthy octogenarians with bladder cancer may be offered radical cystectomy without a significantly increased incidence of postoperative complications.

18 Apr 2007

Brain tumor vaccine shows promise

A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain has shown promise in preliminary data from a clinical trial at the University of California, San Francisco.

17 Apr 2007

Anti-anemia drug darbepoetin alfa no better than placebo for cancer patients

Results from a phase III drug trial indicate that an anti-anemia drug did not significantly decrease the need for blood transfusions in patients not on chemotherapy, and decreased overall patient survival when compared to placebo, according to researchers from the UCLA Medical Center at the 2007 Annual Meeting of the American Association for Cancer Research.

17 Apr 2007

Predicting cancer risk in the long term

Every day, people make assumptions, educated and not, about their risk for developing cancer.

17 Apr 2007

FDA accepts Satraplatin NDA for priority review

Spectrum Pharmaceuticals has announced that the New Drug Application (NDA) for satraplatin has been accepted for priority review by the U.S. Food & Drug Administration (FDA).

17 Apr 2007

Chemotherapy News and Research

Latest Chemotherapy News and Research

Chinese herbs may help women with breast cancer

Preoperative chemotherapy is safe for women with early stage operable breast cancer

Novel method to expand the number of immune system "natural killer" cells from blood cells outside the body

Genta Incorporated announces phase 3 trial of Genasense in patients with advanced melanoma

Vaccines to prevent or slow the growth of cancerous tumors

No survival benefit for gastric cancer patients who undergo intensive postoperative chemotherapy

Factors that dictate risk of developing primary or secondary cancer

Vaccine halts progression of pancreatic cancer in some patients

OncoGenex Technologies announces data from a Phase II clinical trial of OGX-011

North Shore-LIJ seeks participants for liver tumor and new chemo trial

Nanoparticle delivery system delivers cancer-suppressing gene in M. D. Anderson trial

Scientists tackle cancer with different approaches

Polymorphisms in the glutathione S-transferase genes and treatment outcomes in acute myeloid leukemia

Cell Genesys reports data from clinical trials of GVAX immunotherapy for prostate cancer

Cancer patients are at high risk for potential drug interactions

Advanced age associated with poorer bladder cancer-specific survival in radical cystectomy patients

Brain tumor vaccine shows promise

Anti-anemia drug darbepoetin alfa no better than placebo for cancer patients

Predicting cancer risk in the long term

FDA accepts Satraplatin NDA for priority review

Cancer Research - Second Edition eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in